| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |